Effects of Micronutrients on Serum Antioxidant Status of Glaucoma Patients: A Randomized, Placebo-controlled, Double-masked Pilot Study
Journal Title: Ophthalmology Research: An International Journal - Year 2014, Vol 2, Issue 1
Abstract
Aims: Glaucoma is a chronic eye disease, which is associated with progressive optic neurodegeneration and concomitant visual field defects. Besides an elevated intraocular pressure, recent studies have suggested that other risk factors such as oxidative stress may play an important role in the pathogenesis of glaucoma. The goal of this study was to examine the effects of oral micronutrients on the antioxidant status in glaucoma patients. Study Design: randomized, placebo-controlled, double-masked pilot study. Place and Duration of Study: Ophthalmological Clinic Oculus Parter-Bucharest, Romania, between March 2007 and February 2008. Methodology: This study was conducted with 40 glaucoma patients receiving either oral supplementation of micronutrients containing 150 mg α-lipoic acid, 36 mg vitamin E, 70 mg vitamin C, 3.6 mg vitamin B1, 5 µg vitamin B12, and 100 mg bilberry extract (Ocuvite® Glaukom) or placebo tablets for a duration of six months. Effects of oral micronutrients on uric acid, ascorbic acid, and tocopherol serum concentrations were investigated in a subgroup of 25 patients. The safety of the supplementation was assessed in 40 patients. Results: Supplementation with oral micronutrients for six months showed a minor increase of antioxidant serum levels without statistical significance (uric acid: P = 0.14; ascorbic acid: P = 0.11; tocopherol: P = 0.32). Safety data were satisfactory. Conclusion: There were no statistically significant differences between both treatment groups, which may be explained by the short study period and the small sample size. Further extensive studies are required to verify the hypothesis that oral supplementation of micronutrients may influence the antioxidant status in glaucoma patients.
Authors and Affiliations
Alice L. Yu, Ozana Moraru, Carl Erb, Ulrich Welge-Lussen
Keywords
Related Articles
- EP ID EP338898
- DOI 10.9734/OR/2014/5926
- Views 102
- Downloads 0
Calcinosis Cutis of the Eyelid
We report a case of calcinosis cutis presenting in the upper eyelid. These cases can mimic various conditions of the eyelid and diagnosis is usually done histopathologically. Though they are common occurrence for dermato...
Repeated Intravitreal Bevacizumab Injections versus Single Combined Intravitreal Bevacizumab and Posterior Subtenon Triamcinolone Injections for Treatment of Diabetic Macular Edema
Aim: To compare efficacy of combined intravitreal bevacizumab and subtenon triamcinolone versus three intravitreal injections of bevacizumab at one month interval for reducing foveal thickness. Methods: Sixty eyes of 30...
Association of the CASQ1 Gene SNP rs3838216 with Graves’ Ophthalmopathy and Hashimoto’s Thyroiditis in Patients with Thyroid Autoimmunity
The pathogenesis of Graves’ ophthalmopathy is poorly understood, but there is evidence for the involvement of calsequestrin (CASQ1) as an autoantigen. Aim: To compare the frequency of the single nucleotide polymorphism...
Visual Pathway Tumor Presenting as Visual Disturbances without Extraocular Signs
Purpose: To evaluate visual pathway tumor presenting as visual disturbances without extraocular signs and assess the usefulness of various examinations. Methods: Only 35 patients with intracranial tumors (22 males and 13...
Intravitreal Dexamethasone Implant Plus Prompt Grid Laser for Macular Edema Due to Retinal Vein Occlusion
Purpose: To evaluate the use of intravitreal dexamethasone implant followed by prompt grid laser for macular edema secondary to retinal vein occlusion (RVO). Methods: Prospective, non-controlled, 12-month interventional...